Ocular Therapeutix Inc (NASDAQ:OCUL) shares are sliding almost 5% today on the heels of the biotech firm’s President and CEO Antony Mattessich new …
H.C.
Yesterday, drug maker Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced the beginning of Phase 3 trial AURORA of voclosporin, a medicine intended to treat lupus …
Last week, on April 20, during the National Kidney Foundation 2017 Spring Clinical Meeting in Orland, Florida, Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) announced some …
In a research report issued Thursday, H.C.
There were cheers from Steadymed (NASDAQ:STDY) investors last Friday following The Patent Trial and Appeal Board’s (PTAB) favorable decision granted to the biotech firm …
Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares are falling almost 8% amid an unfortunate setback with the firm’s MoveDMD Part B data read-out that failed …
Karyopharm Therapeutics Inc (NASDAQ:KPTI) shares are falling 16% after the biotech firm’s Phase 2 trial evaluating Selinexor in Older Patients with Relapsed Acute …
